Appendix E

References

REFERENCES CITED IN THE REPORT

AAP (American Academy of Pediatrics). 2009a. Hepatitis B. In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 337-356.

AAP. 2009b. Measles. In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 444-455.

AAP. 2009c. Rubella. In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 579-584.

AAP. 2009d. Tetanus (lockjaw). In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 655-660.

AAP. 2009e. Varicella-zoster infections. In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 714-727.

Abdul-Ghaffar, N. U. A. M. A., and K. N. Achar. 1994. Brown-Sequard syndrome following diphtheria and tetanus vaccines. Tropical Doctor 24(2):74-75.

Abe, T., C. Nonaka, M. Hiraiwa, H. Ushijima, and R. Fujii. 1985. Acute and delayed neurologic reaction to inoculation with attenuated live measles virus. Brain and Development 7(4):421-423.

Abu-Shakra, M., S. Zalmanson, L. Neumann, D. Flusser, S. Sukenik, and D. Buskila. 2000. Influenza virus vaccination of patients with systemic lupus erythematosus: Effects on disease activity. Journal of Rheumatology 27(7):1681-1685.

Adams, E. B. 1968. The prognosis and prevention of tetanus human. South African Medical Journal 42(29):739-743.

Adverse Drug Reactions Advisory Committee. 1996. Hepatitis B vaccines—musculoskeletal reactions. Australian Adverse Drug Reactions Bulletin 15(2).



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 749
Appendix E References REFERENCES CITED IN THE REPORT AAP (American Academy of Pediatrics). 2009a. Hepatitis B. In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 337-356. AAP. 2009b. Measles. In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 444-455. AAP. 2009c. Rubella. In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 579-584. AAP. 2009d. Tetanus (lockjaw). In Red book: 2009 Report of the Committee on Infectious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 655-660. AAP. 2009e. Varicella-zoster infections. In Red book: 2009 Report of the Committee on Infec- tious Diseases, 28th ed., edited by L. K. Pickering, C. J. Baker, D. W. Kimberlin, and S. S. Long. Elk Grove Village, IL: American Academy of Pediatrics. Pp. 714-727. Abdul-Ghaffar, N. U. A. M. A., and K. N. Achar. 1994. Brown-Sequard syndrome following diphtheria and tetanus vaccines. Tropical Doctor 24(2):74-75. Abe, T., C. Nonaka, M. Hiraiwa, H. Ushijima, and R. Fujii. 1985. Acute and delayed neuro- logic reaction to inoculation with attenuated live measles virus. Brain and Development 7(4):421-423. Abu-Shakra, M., S. Zalmanson, L. Neumann, D. Flusser, S. Sukenik, and D. Buskila. 2000. Influenza virus vaccination of patients with systemic lupus erythematosus: Effects on disease activity. Journal of Rheumatology 27(7):1681-1685. Adams, E. B. 1968. The prognosis and prevention of tetanus human. South African Medical Journal 42(29):739-743. Adverse Drug Reactions Advisory Committee. 1996. Hepatitis B vaccines—musculoskeletal reactions. Australian Adverse Drug Reactions Bulletin 15(2). 749

OCR for page 749
750 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Agmon-Levin, N., Y. Zafrir, Z. Paz, T. Shilton, G. Zandman-Goddard, and Y. Shoenfeld. 2009. Ten cases of systemic lupus erythematosus related to hepatitis B vaccine. Lupus 18(13):1192-1197. Aherne, P., and M. Collins. 1995. Psoriatic arthropathy. Irish Medical Journal 88(2):72. Ahlgren, C., A. Oden, K. Toren, and O. Andersen. 2009a. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations. Acta Neurologica Scandinavica 119(5):313-320. Ahlgren, C., K. Toren, A. Oden, and O. Andersen. 2009b. A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk. Euro- pean Journal of Epidemiology 24(9):541-552. Ahmed, A. H., K. G. Nicholson, V. S. Hammersley, and J. Kent. 1997. Influenza vaccination in patients with asthma: Effect on peak expiratory flow, asthma symptoms and use of medication. Vaccine 15(9):1008-1009. Aksu, K., G. Keser, and E. Doganavsargil. 2006. Reactive arthritis following tetanus and rabies vaccinations. Rheumatology International 27(2):209-210. Al Awaidy, S., S. Bawikar, K. R. Prakash, B. Al Rawahi, and A. J. Mohammed. 2010. Surveil- lance of adverse events following immunization: 10 years’ experience in Oman. Eastern Mediterranean Health Journal 16(5):474-480. Albarran, B., L. Goncalves, S. Salmen, L. Borges, H. Fields, A. Soyano, H. Montes, and L. Berrueta. 2005. Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B. APMIS 113(7-8):526-535. Albazzaz, M. K., J. E. Harvey, and E. A. Grilli. 1987. Subunit influenza vaccination in adults with asthma: Effect on clinical state, airway reactivity, and antibody response. British Medical Journal 294(6581):1196-1197. Albert, L. J., and R. D. Inman. 1999. Molecular mimicry and autoimmunity. New England Journal of Medicine 341(27):2068-2074. Albitar, S., B. Bourgeon, R. Genin, M. Fen-Chong, P. N’Guyen, M. O. Serveaux, H. Atchia, and D. Schohn. 1997. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrology Dialysis Transplantation 12(10):2169-2170. Aletaha, D., T. Neogi, A. J. Silman, J. Funovits, D. T. Felson, C. O. Bingham, 3rd, N. S. Birnbaum, G. R. Burmester, V. P. Bykerk, M. D. Cohen, B. Combe, K. H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J. M. Hazes, K. Hobbs, T. W. Huizinga, A. Kavanaugh, J. Kay, T. K. Kvien, T. Laing, P. Mease, H. A. Menard, L. W. Moreland, R. L. Naden, T. Pincus, J. S. Smolen, E. Stanislawska-Biernat, D. Symmons, P. P. Tak, K. S. Upchurch, J. Vencovsky, F. Wolfe, and G. Hawker. 2010. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism 62(9):2569-2581. Ali, Z., S. N. Raja, U. Wesselmann, P. N. Fuchs, R. A. Meyer, and J. N. Campbell. 2000. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 88(2):161-168. Allen, M. B., P. Cockwell, and R. L. Page. 1993. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax 48(5):580-581. Alpay, H., N. Yildiz, A. Onar, H. Temizer, and S. Ozcay. 2002. Varicella vaccination in chil- dren with steroid-sensitive nephrotic syndrome. Pediatric Nephrology 17(3):181-183. Alter, H. J., R. H. Purcell, J. L. Gerin, W. T. London, P. M. Kaplan, V. J. McAuliffe, J. Wagner, and P. V. Holland. 1977. Transmission of hepatitis B to chimpanzees by hepatitis B sur- face antigen-positive saliva and semen. Infection and Immunity 16(3):928-933. Altobelli, E., R. Petrocelli, A. Verrotti, and M. Valenti. 2003. Infections and risk of type I diabetes in childhood: A population-based case-control study. European Journal of Epi- demiology 18(5):425-430.

OCR for page 749
751 APPENDIX E Amsel, S. G., A. Hanukoglu, D. Fried, and M. Wolyvovics. 1986. Myocarditis after triple immunisation. Archives of Disease in Childhood 61(4):403-405. Anagnostou, E., and M. J. Taylor. 2011. Review of neuroimaging in autism spectrum disor- ders: What have we learned and where we go from here. Molecular Autism 2(1):4. Andelman, S. L., M. B. Andelman, J. Zackler, and A. Schwarz. 1963. Experimental vaccination against measles: Clinical evaluation of a highly attenuated live measles vaccine. Journal of the American Medical Association 184(9):721-723. Anderson, J. A., and J. I. Weitz. 2010. Hypercoagulable states. Clinics in Chest Medicine 31(4):659-673. Anderson, L. J., and J. F. Seward. 2008. Mumps epidemiology and immunity—the anatomy of a modern epidemic. Pediatric Infectious Disease Journal 27(10):S75-S79. Anderson, P., M. E. Pichichero, and R. A. Insel. 1985. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of hemophilus-influenzae type-B. Journal of Pediatrics 107(3):346-351. Andrews, N., J. Stowe, E. Miller, and B. Taylor. 2007. Post-licensure safety of the meningococ- cal group C conjugate vaccine. Human Vaccines 3(2):59-63. Angelini, P., F. Kavadas, N. Sharma, S. E. Richardson, G. Tipples, C. Roifman, Y. Dror, and Y. Nofech-Mozes. 2009. Aplastic anemia following varicella vaccine. Pediatric Infectious Disease Journal 28(8):746-748. Angerstein, W. 1995. Evaluation of possible causal connections between isolated vestibulo- cochlear lesions and vaccinations in early childhood [in German]. Oto-Rhino-Laryngologia Nova 5(2):67-75. Anlar, B., K. Yalaz, and R. Dizmen. 1989. Long-term prognosis after neonatal tetanus. Devel- opmental Medicine and Child Neurology 31(1):76-80. Anton, H. A. 1993. Frozen shoulder. Canadian Family Physician 39:1773-1778. Antony, S. J., D. F. Fleming, and T. K. Bradley. 1995. Postvaccinial (influenza) disseminated encephalopathy (Brown-Sequard syndrome). Journal of the National Medical Associa- tion 87(9):705-708. Apicella, M. A. 2010. Neisseria meningitidis. In Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. 2 vols. Vol. 2, edited by G. L. Mandell, J. E. Bennett, and R. Dolin. Philadelphia, PA: Churchill Livingstone Elsevier. Pp. 2737-2751. Arthur, W., and G. C. Kaye. 2000. The pathophysiology of common causes of syncope. Post- graduate Medical Journal 76(902):750-753. Arvin, A. M. 1996. Varicella-zoster virus. Clinical Microbiology Reviews 9(3):361-381. Arvin, A. M., and A. A. Gershon. 1996. Live attenuated varicella vaccine. Annual Review of Microbiology 50:59-100. Asakawa, J., S. Kobayashi, K. Kaneda, H. Ogasawara, M. Sugawara, M. Yasuda, and H. Hashimoto. 2005. Reactive arthritis after influenza vaccination: Report of a case. Mod- ern Rheumatology 15(4):283-285. Asatryan, A., V. Pool, R. T. Chen, K. S. Kohl, R. L. Davis, J. K. Iskander, and V. Team. 2008. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990-2003. Vaccine 26(9):1166-1172. Ascherio, A., S. M. Zhang, M. A. Hernan, M. J. Olek, P. M. Coplan, K. Brodovicz, and A. M. Walker. 2001. Hepatitis B vaccination and the risk of multiple sclerosis. New England Journal of Medicine 344(5):327-332. Ashkenazi, S., A. Vertruyen, J. Arístegui, S. Esposito, D. D. McKeith, T. Klemola, J. Biolek, J. Kühr, T. Bujnowski, D. Desgrandchamps, S. M. Cheng, J. Skinner, W. C. Gruber, and B. D. Forrest. 2006. Superior relative efficacy of live attenuated influenza vaccine com- pared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatric Infectious Disease Journal 25(10):870-879.

OCR for page 749
752 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Aspinall, G. O., S. Fujimoto, A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994a. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infection and Immunity 62(5):2122-2125. Aspinall, G. O., A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994b. Lipo- polysaccharides of Campylobacter jejuni serotype O:19: Structures of core oligosac- charide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome. Biochemistry 33(1):241-249. Atanasoff, S., T. Ryan, R. Lightfoot, and R. Johann-Liang. 2010. Shoulder injury related to vaccine administration (SIRVA). Vaccine 28(51):8049-8052. Atmar, R. L., K. Bloom, W. Keitel, R. B. Couch, and S. B. Greenberg. 1990. Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults. Vaccine 8(3):217-224. Audenaert, D., C. Van Broeckhoven, and P. De Jonghe. 2006. Genes and loci involved in febrile seizures and related epilepsy syndromes. Human Mutation 27(5):391-401. Augey, F., D. Legoff, and B. Chouvet. 2003. Bullous eruption after influenza virus vaccination [in French]. Annales de Dermatologie et de Venereologie 130(11):1058-1060. Aukrust, L., T. L. Almeland, D. Refsum, and K. Aas. 1980. Severe hypersensitivity or intoler- ance reactions to measles vaccine in six children. Clinical and immunological studies. Allergy: European Journal of Allergy and Clinical Immunology 35(7):581-587. Austgulen, R. 1985. Immunization of children with malignant diseases with the Oka-strain varicella vaccine. Postgraduate Medical Journal 61(Suppl. 4):93-95. Avner, J. R. 2009. Acute fever. Pediatrics in Review 30(1):5-13; quiz 13. Axnick, N. W., and E. R. Alexander. 1957. Tetanus in the United States: A review of the problem. American Journal of Public Health and the Nations Health 47(12):1493-1501. Aydin, K., S. Elmas, and E. A. Guzes. 2006. Reversible posterior leukoencephalopathy and Adie’s pupil after measles vaccination. Journal of Child Neurology 21(6):525-527. Babbott, F. L., and J. E. Gordon. 1954. Modern measles. American Journal of the Medical Sciences 228(3):334-361. Babcock, H. M., L. R. Merz, and V. J. Fraser. 2006. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infection Control and Hospital Epidemiology 27:266-270. Bakshi, N., J. Lawson, R. Hanson, C. Ames, and H. V. Vinters. 1996. Fatal mumps menin- goencephalitis in a child with severe combined immunodeficiency after bone marrow transplantation. Journal of Child Neurology 11(2):159-162. Bakshi, R., and M. C. Graves. 1997. Guillain-Barré syndrome after combined tetanus- diphtheria toxoid vaccination. Journal of the Neurological Sciences 147(2):201-202. Bakshi, R., and J. C. Mazziotta. 1996. Acute transverse myelitis after influenza vaccination: Magnetic resonance imaging findings. Journal of Neuroimaging 6(4):248-250. Balci, Y., M. Tok, B. K. Kocaturk, C. Yenilmez, and C. Yorulmaz. 2007. Simultaneous sudden infant death syndrome. Journal of Forensic and Legal Medicine 14(2):87-91. Balfour, H. H., Jr., C. L. Balfour, C. K. Edelman, and P. A. Rierson. 1976. Evaluation of wi- star RA27/3 rubella virus vaccine in children. American Journal of Diseases of Children 130(10):1089-1091. Balfour, H. H., Jr., K. E. Groth, and C. K. Edelman. 1980. RA27/3 rubella vaccine. A four-year follow-up. American Journal of Diseases of Children 134(4):350-353. Ball, R., M. M. Braun, G. T. Mootrey, S. Ellenberg, S. Rastogi, C. Krueger, R. Wise, M. Niu, D. Davis, F. Varricchio, P. Perucci, T. DuVernoy, R. Chen, P. Haber, V. Pool, W. Wattigney, T. Strine, R. Pless, V. Caserta, and G. Evans. 2001. Safety data on meningococcal polysac- charide vaccine from the Vaccine Adverse Event Reporting System. Clinical Infectious Diseases 32(9):1273-1280.

OCR for page 749
753 APPENDIX E Balosso, S., M. Maroso, M. Sanchez-Alavez, T. Ravizza, A. Frasca, T. Bartfai, and A. Vezzani. 2008. A novel non-transcriptional pathway mediates the proconvulsive effects of inter- leukin-1beta. Brain 131(Pt 12):3256-3265. Bancillon, A., T. Leblanc, A. Baruchel, G. Schaison, G. Leverger, D. Mallarmey, and L. Teuliere. 1991. Study of tolerance and effectiveness of a varicella vaccine in leukemic children. Nouvelle Revue Francaise d Hematologie 33(6):555-556. Bancroft, W. H., R. M. Scott, W. T. Watson, and J. J. Karwacki. 1977. Transmission of hepati- tis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. Journal of Infectious Diseases 135(1):79-85. Baram, T. Z., I. Gonzalez-Gomez, Z. D. Xie, D. Yao, F. H. Gilles, M. D. Nelson, Jr., H. T. Nguyen, and J. Peters. 1994. Subacute sclerosing panencephalitis in an infant: Diagnostic role of viral genome analysis. Annals of Neurology 36(1):103-108. Barker, W. H. 1986. Excess pneumonia and influenza associated hospitalization during in- fluenza epidemics in the United States, 1970-78. American Journal of Public Health 76(7):761-765. Barlow, J. L., V. Mung’ala-Odera, J. Gona, and C. Newton. 2001a. Brain damage after neo- natal tetanus in a rural Kenyan hospital. Tropical Medicine and International Health 6(4):305-308. Barlow, W. E., R. L. Davis, J. W. Glasser, P. H. Rhodes, R. S. Thompson, J. P. Mullooly, S. B. Black, H. R. Shinefield, J. I. Ward, S. M. Marcy, F. DeStefano, and R. T. Chen. 2001b. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. New England Journal of Medicine 345(9):656-661. Barnett, L. A., J. L. Whitton, L. Y. Wang, and R. S. Fujinami. 1996. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. Journal of Neuroimmunology 64(2):163-173. Barton, M., S. Wasfy, T. Melbourne, D. Hebert, D. Moore, J. Robinson, R. D. Marchese, and U. D. Allen. 2009. Sustainability of humoral responses to varicella vaccine in pediatric transplant recipients following a pretransplantation immunization strategy. Pediatric Transplantation 13(8):1007-1013. Barzaga, N. G., R. H. Florese, and H. L. Bock. 2002. Reactogenicity and immunogenicity of a varicella vaccine in healthy seronegative and seropositive subjects. Southeast Asian Journal of Tropical Medicine and Public Health 33(2):259-267. Battaglia, A., and R. Valiani. 1992. Description of case of seizure following anti-hepatitis B immunization [in Italian]. Rassegna di Medicina Sperimentale 39(7-9):119-122. Baxter, D. N. 1996. Measles immunization in children with a history of egg allergy. Vaccine 14(2):131-134. Beasley, R. P., L. Y. Hwang, G. C. Y. Lee, C. C. Lan, C. H. Roan, F. Y. Huang, and C. L. Chen. 1983. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2(8359):1099-1102. Bedard Marrero, V., R. L. Osorio Figueroa, and O. Vazquez Torres. 2010. Guillain-Barré syndrome after influenza vaccine administration: Two adult cases. Boletin—Asociacion Medica de Puerto Rico 102(2):39-41. Bedard, P. M., and G. Gascon. 1999. Fatal outcome of systemic vasculitis following influenza vaccination. Canadian Journal of Allergy and Clinical Immunology 4(8):405-406. Begier, E. M., C. A. Langford, M. C. Sneller, R. P. Wise, R. Ball, and V. W. Group. 2004. Polyarteritis nodosa reports to the Vaccine Adverse Event Reporting System (VAERS): Implications for assessment of suspected vaccine-provoked vasculitis. Journal of Rheu- matology 31(11):2181-2188. Behan, P. O. 1977. Diffuse myelitis associated with rubella vaccination. British Medical Jour- nal 1(6054):166. Bell, T. D., H. Chai, B. Berlow, and G. Daniels. 1978. Immunization with killed influenza virus in children with chronic asthma. Chest 73(2):140-145.

OCR for page 749
754 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Bellamy, J. D., D. J. Booker, N. T. James, R. Stamps, and R. J. Sokol. 1997. Measurement of red blood cell-bound C3b and C3d using an enzyme-linked direct antiglobulin test. Immunohematology 13(4):123-131. Bellut, A., E. Laveine, W. Kaise, I. Vivard-Wallee, J. L. Schmutz, and A. Barbaud. 2001. Cuta- neous manifestations due to vaccines: Prospective study in Lorraine (France) [in French]. Nouvelles Dermatologiques 20(3):152-155. Belshe, R., R. Walker, J. Stoddard, G. Kemble, H. Maassab, and P. Mendelman. 2008. Chapter 16. Influenza vaccine-live. In Vaccines, edited by S. A. Plotkin, W. A. Orenstein, and P. A. Offit. Philadelphia, PA: Saunders/Elsevier. Pp. 291-309. Belshe, R. B., K. M. Edwards, T. Vesikari, S. V. Black, R. E. Walker, M. Hultquist, G. Kemble, and E. M. Connor. 2007. Live attenuated versus inactivated influenza vaccine in infants and young children. New England Journal of Medicine 356(7):685-696. Belshe, R. B., K. L. Nichol, S. B. Black, H. Shinefield, J. Cordova, R. Walker, C. Hessel, I. Cho, and P. M. Mendelman. 2004. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Clinical Infec- tious Diseases 39(7):920-927. Bengtsson, C., M. C. Kapetanovic, H. Kallberg, B. Sverdrup, B. Nordmark, L. Klareskog, L. Alfredsson, G. Lindahl, H. Hellstrom, F. Lasarett, T. Weitoft, B. Lindell, J. Bratt, I. Hafstrom, I. Leden, B. Lofstrom, A. Bengtsson, T. Skogh, E. Lindqvist, L. Jacobsson, K. Huddenius, C. Lindstrom, A. Teleman, E. Baecklund, A. Knight, O. Svernell, and P. Stolt. 2010. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: Results from the Swedish EIRA study. Annals of the Rheumatic Diseases 69(10):1831-1833. Benjamin, C. M., G. C. Chew, and A. J. Silman. 1992. Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine. British Medical Journal 304(6834):1075-1078. Benke, G., M. Abramson, J. Raven, F. C. K. Thien, and E. H. Walters. 2004. Asthma and vaccination history in a young adult cohort. Australian and New Zealand Journal of Public Health 28(4):336-338. Bensasson, M., R. Lanoe, and R. Assan. 1977. A case of algodystrophic syndrome of the upper limb following tetanus vaccination [in French]. Semaine des Hopitaux 53(36):1965-1966. Bentsi-Enchill, A. D., I. Zongo, S. Khamassi, R. Pless, R. Thombiano, S. Tiendrebeogo, C. B. Nelson, and P. Duclos. 2007. Monitoring of adverse events during the 2003 mass vac- cination campaign with a trivalent meningococcal a/c/W135 polysaccharide vaccine in Burkina Faso. Vaccine 25(Suppl. 1):A72-A78. Beretta, L., M. Caronni, M. Vanoli, and R. Scorza. 2001. Churg-Strauss vasculitis with brain involvement following hepatitis B vaccination. Clinical and Experimental Rheumatology 19(6):757. Bergeisen, G. H., M. W. Hinds, and J. W. Skaggs. 1985. A waterborn outbreak of hepatitis A in Meade County, Kentucky. American Journal of Public Health 75(2):161-168. Bergen, R., S. Black, H. Shinefield, E. Lewis, P. Ray, J. Hansen, R. Walker, C. Hessel, J. Cordova, and P. M. Mendelman. 2004. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatric Infectious Disease Journal 23(2):138-144. Berger, B. E., A. M. Navar-Boggan, and S. B. Omer. 2011. Congenital rubella syndrome and autism spectrum disorder prevented by rubella vaccination—United States, 2001-2010. BMC Public Health 11:340. Berkovic, S. F., L. Harkin, J. M. McMahon, J. T. Pelekanos, S. M. Zuberi, E. C. Wirrell, D. S. Gill, X. Iona, J. C. Mulley, and I. E. Scheffer. 2006. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: A retrospective study. Lancet Neurology 5(6):488-492.

OCR for page 749
755 APPENDIX E Bernstein, D. I., F. Y. Aoki, S. K. Tyring, L. R. Stanberry, C. St.-Pierre, S. D. Shafran, G. Leroux-Roels, K. Van Herck, A. Bollaerts, and G. Dubin. 2005. Safety and immuno- genicity of glycoprotein d-adjuvant genital herpes vaccine. Clinical Infectious Diseases 40(9):1271-1281. Berry, P. A., and G. Smith-Laing. 2007. Hepatitis A vaccine associated with autoimmune hepatitis. World Journal of Gastroenterology 13(15):2238-2239. Best, J. M., J. E. Banatvala, and J. M. Bowen. 1974. New Japanese rubella vaccine: Compara- tive trials. British Medical Journal 3(5925):221-224. Beytout, J., O. Launay, N. Guiso, A. Fiquet, M. Baudin, P. Richard, C. Baptiste, and B. Soubeyrand. 2009. Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial. Human Vaccines 5(5):315-321. Bhatia, R. S. 1985. Hypersensitivity to tetanus toxoid injection. Indian Journal of Dermatol- ogy, Venereology and Leprology 51(3):177. Bhatla, N., V. Suri, P. Basu, S. Shastri, S. K. Datta, D. Bi, D. J. Descamps, and H. L. Bock. 2010. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cer- vical cancer vaccine in healthy Indian women. Journal of Obstetrics and Gynaecology Research 36(1):123-132. Biasi, D., A. Carletto, P. Caramaschi, A. Frigo, M. L. Pacor, D. Bezzi, and L. M. Bambara. 1994a. Rheumatic manifestations following hepatitis B vaccination. Two case reports [in Italian]. Recenti Progressi in Medicina 85(9):438-440. Biasi, D., A. Carletto, P. Caramaschi, M. Tonoli, and L. M. Bambara. 1994b. A case of reactive arthritis after influenza vaccination. Clinical Rheumatology 13(4):645. Biasi, D., G. De Sandre, L. M. Bambara, A. Carletto, P. Caramaschi, G. Zanoni, and G. Tridente. 1993. A new case of reactive arthritis after hepatitis B vaccination. Clinical and Experimental Rheumatology 11(2):215. Bilyk, M. A., and G. K. Dubchik. 1978. Anaphylactic reaction following subcutaneous ad- ministration of tetanus anatoxin [in Russian]. Klinicheskaia Meditsina 56(9):137-138. Bino, S., E. Kakarriqi, M. Xibinaku, N. Ion-Nedelcu, M. Bukli, N. Emiroglu, and A. Uzicanin. 2003. Measles-rubella mass immunization campaign in Albania, November 2000. Jour- nal of Infectious Diseases 187(Suppl. 1):S223-S229. Birck, R., I. Kaelsch, P. Schnuelle, L. F. Flores-Suarez, and R. Nowack. 2009. ANCA- associated vasculitis following influenza vaccination: Causal association or mere coinci- dence? Journal of Clinical Rheumatology 15(6):289-291. Bitnun, A., P. Shannon, A. Durward, P. A. Rota, W. J. Bellini, C. Graham, E. Wang, E. L. Ford-Jones, P. Cox, L. Becker, M. Fearon, M. Petric, and R. Tellier. 1999. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clinical Infec- tious Diseases 29(4):855-861. Black, F. L., S. H. Lamm, J. E. Emmons, and F. P. Pinheiro. 1976. Reactions to rubella vaccine and persistence of antibody in virgin-soil populations after vaccination and wild-virus- induced immunization. Journal of Infectious Diseases 133(4):393-398. Black, S., H. Shinefield, J. Hansen, E. Lewis, L. Su, and P. Coplan. 2004. A post-licensure evaluation of the safety of inactivated hepatitis A vaccine (VAQTA, Merck) in children and adults. Vaccine 22(5-6):766-772. Black, S., H. Shinefield, P. Ray, E. Lewis, R. Chen, J. Glasser, S. Hadler, J. Hardy, P. Rhodes, E. Swint, R. Davis, R. Thompson, J. Mullooly, M. Marcy, C. Vadheim, J. Ward, S. Rastogi, and R. Wise. 1997. Risk of hospitalization because of aseptic meningitis after measles- mumps-rubella vaccination in one- to two-year-old children: An analysis of the Vaccine Safety Datalink (VSD) project. Pediatric Infectious Disease Journal 16(5):500-503. Black, S., H. Shinefield, P. Ray, E. Lewis, J. Hansen, J. Schwalbe, P. Coplan, R. Sharrar, and H. Guess. 1999. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatric Infectious Disease Journal 18(12):1041-1046.

OCR for page 749
756 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Blanco-Marchite, C. I., L. Buznego-Suarez, M. A. Fagundez-Vargas, M. Mendez-Llatas, and P. Pozo-Martos. 2008. Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination [in Spanish]. Archivos de la Sociedad Espanola de Oftalmologia 83(7):433-435. Blanco, A., J. M. Lopez Dominguez, J. L. Casado, and C. Diaz. 1999. Meningoencephalitis: An unusual complication of influenza vaccine [in Spanish]. Medicina Clinica 112(15):597. Bloch, A. B., S. L. Stramer, J. D. Smith, H. S. Margolis, H. A. Fields, T. W. McKinley, C. P. Gerba, J. E. Maynard, and R. K. Sikes. 1990. Recovery of hepatitis A virus from a water supply responsible for a common source outbreak of hepatitis A. American Journal of Public Health 80(4):428-430. Block, S. L., D. R. Brown, A. Chatterjee, M. A. Gold, H. L. Sings, A. Meibohm, A. Dana, R. M. Haupt, E. Barr, G. M. Tamms, H. Zhou, and K. S. Reisinger. 2010. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine. Pediatric Infectious Disease Journal 29(2):95-101. Blom, L., L. Nystrom, and G. Dahlquist. 1991. The Swedish childhood diabetes study. Vac- cinations and infections as risk determinants for diabetes in childhood. Diabetologia 34(3):176-181. Blumberg, B. S., and H. J. Alter. 1965. A “new” antigen in leukemia sera. Journal of the American Medical Association 191(7):541-546. Blumberg, S., D. Bienfang, and F. G. Kantrowitz. 1980. A possible association between influenza vaccination and small-vessel vasculitis. Archives of Internal Medicine 140(6):847-848. Blumenthal, D., D. Prais, E. Bron-Harlev, and J. Amir. 2004. Possible association of Guillain- Barré syndrome and hepatitis A vaccination. Pediatric Infectious Disease Journal 23(6): 586-588. Bogdanovic, J., N. A. Halsey, R. A. Wood, and R. G. Hamilton. 2009. Bovine and porcine gelatin sensitivity in children sensitized to milk and meat. Journal of Allergy and Clinical Immunology 124(5):1108-1110. Bohlke, K., R. L. Davis, S. M. Marcy, M. M. Braun, F. DeStefano, S. B. Black, J. P. Mullooly, and R. S. Thompson. 2003. Risk of anaphylaxis after vaccination of children and ado- lescents. Pediatrics 112(4):815-820. Boling, H. L. 1980. An adult’s reaction to measles vaccine. American Journal of Nursing 80(8):1442-1443. Bolukbasi, O., and M. Ozmenoglu. 1999. Acute disseminated encephalomyelitis associated with tetanus vaccination. European Neurology 41(4):231-232. Bonnez, W., and R. C. Reichman. 2010. Papillomaviruses. In Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. 2 vols. Vol. 2, edited by G. L. Mandell, J. E. Bennett, and R. Dolin. Philadelphia, PA: Churchill Livingstone Elsevier. Pp. 2035-2049. Borja-Hart, N. L., S. Benavides, and C. Christensen. 2009. Human papillomavirus vaccine safety in pediatric patients: An evaluation of the vaccine adverse event reporting system. Annals of Pharmacotherapy 43(2):356-359. Borte, S., U. G. Liebert, M. Borte, and U. Sack. 2009. Efficacy of measles, mumps, and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology 48(2):144-148. Bottiger, M., L. Heller, and S. I. Rollof. 1974. Rubella vaccination of teen-age girls [in Swed- ish]. Lakartidningen 71(19):1949-1951. Bourgeais, A. M., M. X. Dore, A. Croue, C. Leclech, and J. L. Verret. 2003. Cutaneous poly- arteritis nodosa following hepatitis B vaccination [in French]. Annales de Dermatologie et de Venereologie 130(2 Pt 1):205-207. Boutros, N., and B. P. Keck. 1993. Delirium following influenza vaccination. American Journal of Psychiatry 150(12):1899.

OCR for page 749
757 APPENDIX E Bracci, M., and A. Zoppini. 1997. Polyarthritis associated with hepatitis B vaccination. British Journal of Rheumatology 36(2):300-301. Braun, M. M., P. A. Patriarca, and S. S. Ellenberg. 1997. Syncope after immunization. Archives of Pediatrics and Adolescent Medicine 151(3):255-259. Bray, P. F. 1972. Mumps: A cause of hydrocephalus? Pediatrics 49(3):446-449. Bridges, C. B., J. Katz, R. Levandowski, and N. Cox. 2008. Chapter 15. Inactivated influenza vaccines. In Vaccines, edited by S. A. Plotkin, W. A. Orenstein, and P. A. Offit. Philadel- phia, PA: Saunders/Elsevier. Pp. 259-290. Brinar, V. V., and C. M. Poser. 2008. Disseminated encephalomyelitis in adults. Clinical Neu- rology and Neurosurgery 110(9):913-918. Brodman, R., R. Gilfillan, D. Glass, and P. H. Schur. 1978. Influenzal vaccine response in systemic lupus erythematosus. Annals of Internal Medicine 88(6):735-740. Brodsky, L., and J. Stanievich. 1985. Sensorineural hearing loss following live measles virus vaccination. International Journal of Pediatric Otorhinolaryngology 10(2):159-163. Brooks, R., and A. Reznik. 1980. Guillain-Barré syndrome following trivalent influenza vac- cine in an elderly patient. Mount Sinai Journal of Medicine 47(2):190-191. Brostoff, J. M., Y. Beitverda, and J. Birns. 2008. Post-influenza vaccine chronic inflammatory demyelinating polyneuropathy. Age and Ageing 37(2):229-230. Brotherton, J. M. L., M. S. Gold, A. S. Kemp, P. B. McIntyre, M. A. Burgess, and S. Campbell- Lloyd. 2008. Anaphylaxis following quadrivalent human papillomavirus vaccination. Canadian Medical Association Journal 179(6):525-533. Brown, M. A., J. V. Bertouch, and J. Edmonds. 1994. Rheumatic complications of influenza vaccination. Australian and New Zealand Journal of Medicine 24(5):572-573. Broyer, M., and B. Boudailliez. 1985. Varicella vaccine in children with chronic renal insuf- ficiency. Postgraduate Medical Journal 61(Suppl. 4):103-106. Bruce, D. 1920. Tetanus. Analysis of 1458 cases, which occurred in home military hospitals during the years 1914-1918. Journal of Hygiene 19(1):1-32. Brue, S., A. Valentin, M. Forssblad, S. Werner, C. Mikkelsen, and G. Cerulli. 2007. Idio- pathic adhesive capsulitis of the shoulder: A review. Knee Surgery, Sports Traumatology, Arthroscopy 15(8):1048-1054. Bruehl, S. 2010. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology 113(3):713-725. Brunell, P. A., C. F. Geiser, V. Novelli, S. Lipton, and S. Narkewicz. 1987. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics 79(6):922-927. Brunell, P. A., Z. Shehab, C. Geiser, and J. E. Waugh. 1982. Administration of live varicella vaccine to children with leukaemia. Lancet 2(8307):1069-1072. Bruyn, G. A., B. J. Zegers, and R. van Furth. 1992. Mechanisms of host defense against infec- tion with streptococcus pneumoniae. Clinical Infectious Diseases 14(1):251-262. Bryan, C. J., M. N. Prichard, S. Daily, G. Jefferson, C. Hartline, K. A. Cassady, L. Hilliard, and M. Shimamura. 2008. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma. Pediatric Infectious Disease Journal 27(10):946-948. Buchner, H., A. Ferbert, and R. Hundgen. 1988. Polyneuritis cranialis, brain-stem encephalitis and myelitis following influenza [in German]. Nervenarzt 59(11):679-682. Bueving, H. J., R. M. D. Bernsen, J. C. De Jongste, L. W. A. Van Suijlekom-Smit, G. F. Rimmelzwaan, A. D. M. E. Osterhaus, M. P. M. H. Rutten-Van Molken, S. Thomas, and J. C. Van Der Wouden. 2004. Does influenza vaccination exacerbate asthma in children? Vaccine 23(1):91-96. Bui-Quang, D., E. Thomas, M. Riols, P. Levillain, D. Picaud, A. Sechet, M. Baron, and C. Verove. 1998. Cutaneous vasculitis after hepatitis B vaccination with recombinant vac- cine in a renal transplant recipient [in French]. Presse Medicale 27(26):1321-1323.

OCR for page 749
758 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Burnet, F. M. 1936. Influenza virus on the developing egg: I. Changes associated with the development of an egg-passage strain of virus. British Journal of Experimental Pathol- ogy 17(4):282-293. Burwen, D. R., R. Ball, W. W. Bryan, H. S. Izurieta, L. La Voie, N. A. Gibbs, R. Kliman, and M. M. Braun. 2010. Evaluation of Guillain-Barré syndrome among recipients of influenza vaccine in 2000 and 2001. American Journal of Preventive Medicine 39(4):296-304. Buttery, J. P., S. Madin, N. W. Crawford, S. Elia, S. La Vincente, S. Hanieh, L. Smith, and B. Bolam. 2008. Mass psychogenic response to human papillomavirus vaccination. Medical Journal of Australia 189(5):261-262. Bytchenko, B. 1966. Geographical distribution of tetanus in world 1951-60—a review of problem. Bulletin of the World Health Organization 34(1):71-104. Cabrera-Gomez, J. A., N. Echazabal-Santana, L. Garcia Gonzalez, A. M. Ramos Cedeno, M. O. Rodriguez Roque, O. Lopez Hernandez, J. A. Cabrera Nunez, J. Gonzalez De La Nuez, and L. Tellez. 2002. A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination? [in Spanish]. Revista de Neurologia 34(4):358-363. Cacoub, P., and B. Terrier. 2009. Hepatitis B-related autoimmune manifestations. Rheumatic Diseases Clinics of North America 35(1):125-137. Caillard, J. F., C. Bastard, and P. Czernichow. 1985. Side effects of hepatitis B vaccination (a study in 1047 subjects at the CHR of Rouen) [in French]. LARC Medical 5(3):129-132. Cannata, J., V. Cuesta, V. Peral, I. Maisueche, and J. Herrera. 1981. Reactivation of vasculitis after influenza vaccination. British Medical Journal 283(6290):526. Casals, J. L., and M. A. Vasquez. 1999. Arthritis after hepatitis B vaccination [in Spanish]. Anales de Medicina Interna 16(11):601-602. Casanova, M., and J. Trippe. 2009. Radial cytoarchitecture and patterns of cortical connec- tivity in autism. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 364(1522):1433-1436. Casanova, M. F. 2007. The neuropathology of autism. Brain Pathology 17(4):422-433. Casella, E. B., V. Nudelman, M. M. Felix, E. Amaro, Jr., B. Handfas, J. J. Radvany, A. Stape, and E. Troster. 2007. Acute necrotizing encephalopathy: Patient with a relapsing and lethal evolution [in Portuguese]. Arquivos de Neuro-Psiquiatria 65(2 A):358-361. Cassidy, W. M., G. Jones, K. Williams, A. Deforest, B. Forghani, G. Virella, and C. Venters. 2005. Safety and immunogenicity of concomitant versus nonconcomitant administration of hepatitis B, tetanus-diphtheria, and measles-mumps-rubella vaccines in healthy eleven- to twelve-year-olds. Journal of Adolescent Health 36(3):187-192. Castro, M., A. Dozor, J. Fish, C. Irvin, S. Scharf, M. E. Scheipeter, J. Holbrook, J. Tonascia, and R. Wise. 2001. The safety of inactivated influenza vaccine in adults and children with asthma. New England Journal of Medicine 345(21):1529-1536. Cathebras, P., O. Cartry, M. H. Lafage-Proust, A. Lauwers, S. Acquart, T. Thomas, and H. Rousset. 1996. Arthritis, hypercalcemia, and lytic bone lesions after hepatitis B vaccina- tion. Journal of Rheumatology 23(3):558-560. Cayrol, R., P. Saikali, and T. Vincent. 2009. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica. Annals of the New York Academy of Sciences 1173:478-486. CDC (Centers for Disease Control and Prevention). 1991. Hepatitis B virus: A comprehen- sive strategy for eliminating transmission in the United States through universal child- hood vaccination: Recommendations of the immunization practices advisory committee (ACIP). Morbidity & Mortality Weekly Report 40(RR-13):1-19. CDC. 1997. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 46(RR-7):1-25.

OCR for page 749
759 APPENDIX E CDC. 1998. Measles, mumps, and rubella—vaccine use and strategies for elimination of mea- sles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 47(RR-8):1-57. CDC. 2001. Vaccinia (smallpox) vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. Morbidity & Mortality Weekly Report 50(RR-10). CDC. 2002a. Prevention and control of influenza. Recommendations of the Advisory Com- mittee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 51(RR-3):1-31. CDC. 2002b. Sexually transmitted diseases treatment guidelines 2002. Morbidity & Mortality Weekly Report 51(RR-6):1-78. CDC. 2003a. Tetanus surveillance—United States, 1998-2000. Morbidity & Mortality Weekly Report 52(3):1-8. CDC. 2003b. Using live, attenuated influenza vaccine for prevention and control of influenza: Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 52(RR-13):1-8. CDC. 2005a. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States—recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: Immunization of infants, children, and adoles- cents. Morbidity & Mortality Weekly Report 54(RR16, Suppl. S):1-16, 17-23, 25-31. CDC. 2005b. Prevention and control of meningococcal disease—recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 54(RR7):1-10, 11-21. CDC. 2006a. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States—recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: Immunization of adults. Morbidity & Mortality Weekly Report 55(RR16, Suppl. S):1-16, 17-33. CDC. 2006b. General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 55(RR15, Suppl. S):1-24, 25-47. CDC. 2006c. Prevention of hepatitis A through active or passive immunization—recommen- dations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 55(RR7, Suppl. S):1-12, 13-23. CDC. 2007a. Prevention of varicella—recommendations of the Advisory Committee on Im- munization Practices (ACIP). Morbidity & Mortality Weekly Report 56(RR4, Suppl. S):1-20, 21-40. CDC. 2007b. Quadrivalent human papillomavirus vaccine—recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 56(RR2, Suppl. S):1-12, 13-24. CDC. 2008a. Human rabies prevention. Morbidity & Mortality Weekly Report 57(RR-3):1-36. CDC. 2008b. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 57(RR-4):1-51. CDC. 2008c. Surveillance for acute viral hepatitis—United States, 2006. Morbidity & Mortal- ity Weekly Report 57(SS2, Suppl. S):1-24. CDC. 2010a. 2009 adult vaccination coverage, NHIS. http://www.cdc.gov/vaccines/stats-surv/ nhis/2009-nhis.htm (accessed April 11, 2011). CDC. 2010b. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 59(20):626-629.

OCR for page 749
816 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Wong, S. S., and K. Y. Yuen. 2006. Avian influenza virus infections in humans. Chest 129(1): 156-168. Woo, E. J., N. B. Miller, and R. Ball. 2006. Adverse events after hepatitis A B combination vaccine. Vaccine 24(14):2685-2691. Woods, C. A., and G. W. Ellison. 1964. Encephalopathy following influenza immunization. Journal of Pediatrics 65:745-748. Wright, P. F., S. H. Sell, J. Thompson, and D. T. Karzon. 1976. Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants. Journal of Pediatrics 88(1):31-35. Wu, Z., H. Wu, and Q. Wang. 1999. A case-control study on Guillain-Barré syndrome in children of north China [in Chinese]. Zhonghua Yufang Yixue Zazhi 33(5):279-281. Xu, X. Y., S. E. Lindstrom, M. W. Shaw, C. B. Smith, H. E. Hall, B. A. Mungall, K. Subbarao, N. J. Cox, and A. Klimov. 2004. Reassortment and evolution of current human influenza A and B viruses. Virus Research 103(1-2):55-60. Yahr, M. D., and J. Lobo-Antunes. 1972. Relapsing encephalomyelitis following use of influ- enza vaccine. Archives of Neurology 27(2):182-183. Yanai-Berar, N., O. Ben-Itzhak, J. Green, and F. Nakhoul. 2002. Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clinical Nephrology 58(3):220-223. Yang, Y., S. Sujan, F. Sun, Y. Zhang, Y. Jiang, J. Song, J. Qin, and X. Wu. 2006. Acute metabolic crisis induced by vaccination in seven Chinese patients. Pediatric Neurology 35(2):114-118. Yergeau, A., L. Alain, R. Pless, and Y. Robert. 1996. Adverse events temporally associated with meningococcal vaccines. Canadian Medical Association Journal 154(4):503-507. Yih, W. K., J. D. Nordin, M. Kulldorff, E. Lewis, T. A. Lieu, P. Shi, and E. S. Weintraub. 2009. An assessment of the safety of adolescent and adult tetanus-diphtheria-acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink. Vaccine 27(32):4257-4262. Yiu, E. M., and A. J. Kornberg. 2010. Acute disseminated encephalomyelitis: Determinants and manifestations. In Inflammatory diseases of the central nervous system, edited by T. Kilpatrick, R. M. Ransohoff, and S. Wesselingh. New York, NY: Cambridge University Press. Yokoyama, T., K. Tateishi, K. Tsushima, T. Agatsuma, H. Yamamoto, T. Koizumi, and K. Kubo. 2010. A case of severe ARDS caused by novel swine-origin influenza (A/H1N1pdm) virus: A successful treatment with direct hemoperfusion with polymyxin B-immobilized fiber. Journal of Clinical Apheresis 25(6):350-353. Yoo, W. H. 2010. Adult onset Still’s disease following influenza vaccination. Joint Bone Spine 77(4):373-374. Yuen, K. Y., P. K. S. Chan, M. Peiris, D. N. C. Tsang, T. L. Que, K. F. Shortridge, P. T. Cheung, W. K. To, R. Sung, and A. F. B. Cheng. 1998. Clinical features and rapid viral diagnosis of huma disease associated with avian influenza h5n1 virus. The Lancet 351:467-471. Yuki, N. 2005. Carbohydrate mimicry: A new paradigm of autoimmune diseases. Current Opinion in Immunology 17(6):577-582. Yuki, N., K. Susuki, M. Koga, Y. Nishimoto, M. Odaka, K. Hirata, K. Taguchi, T. Miyatake, K. Furukawa, T. Kobata, and M. Yamada. 2004. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proceedings of the National Academy of Sciences of the United States of America 101(31):11404-11409. Yuki, N., T. Taki, F. Inagaki, T. Kasama, M. Takahashi, K. Saito, S. Handa, and T. Miyatake. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. Journal of Experimental Medicine 178(5):1771-1775. Zaas, A., P. Scheel, A. Venbrux, and D. B. Hellmann. 2001. Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases. Journal of Rheumatology 28(5):1116-1120.

OCR for page 749
817 APPENDIX E Zaloga, G. P., and B. Chernow. 1982. Life-threatening anaphylactic reaction to tetanus toxoid. Annals of Allergy 49(2):107-108. Zamora, I., J. M. Simon, M. E. Da Silva, and A. I. Piqueras. 1994. Attenuated varicella virus vaccine in children with renal transplants. Pediatric Nephrology 8(2):190-192. Zanoni, G., T. M. D. Nguyen, E. Destefani, L. Masala, E. Nardelli, and G. Tridente. 2002. Transverse myelitis after vaccination. European Journal of Neurology 9(6):696-697. Zelenay, S., M. F. Moraes Fontes, C. Fesel, J. Demengeot, and A. Coutinho. 2007. Physio- pathology of natural auto-antibodies: The case for regulation. Journal of Autoimmunity 29(4):229-235. Zhang, J., G. Li, X. Liu, Z. Wang, W. Liu, and X. Ye. 2009. Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA. Journal of General Virology 90(Pt 11):2751-2758. Zheng, D. P., T. K. Frey, J. Icenogle, S. Katow, E. S. Abernathy, K. J. Song, W. B. Xu, V. Yarulin, R. G. Desjatskova, Y. Aboudy, G. Enders, and M. Croxson. 2003. Global distribution of rubella virus genotypes. Emerging Infectious Diseases 9(12):1523-1530. Zheng, W., and S. C. Dreskin. 2007. Thimerosal in influenza vaccine: An immediate hypersen - sitivity reaction. Annals of Allergy, Asthma and Immunology 99(6):574-575. Zhong, W., P. Oschmann, and H. J. Wellensiek. 1997. Detection and preliminary character- ization of circulating immune complexes in patients with Lyme disease. Med Microbiol Immunol 186(2-3):153-158. Zhou, W., V. Pool, F. DeStefano, J. K. Iskander, P. Haber, R. T. Chen, S. Campbell, R. English- Bullard, S. Holmes, A. Khromova, E. Miller, S. Pickering, M. Russell, S. Shadomy, R. Ball, M. M. Braun, D. Burwen, D. Davis, S. S. Ellenberg, P. Perucci, F. Varricchio, R. P. Wise, and J. Woo. 2004. A potential signal of Bell’s palsy after parenteral inactivated influenza vaccines: Reports to the Vaccine Adverse Event Reporting System (VAERS)— United States, 1991-2001. Pharmacoepidemiology and Drug Safety 13(8):505-510. Zielinski, A., and M. Rosinska. 2008. Comparison of adverse effects following immunization with vaccine containing whole-cell vs acellular pertussis components. Przeglad Epide- miologiczny 62(3):589-596. Zimmerman, A. W., H. Jyonouchi, A. M. Comi, S. L. Connors, S. Milstien, A. Varsou, and M. P. Heyes. 2005. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatric Neurology 33(3):195-201. Zimmerman, R. K., and T. R. Pellitieri. 1994. Inadvertent administration of DTP and DT after age six as recorded in the Vaccine Adverse Event Reporting System. Family Practice Research Journal 14(4):353-358. Zimmerman, R. K., M. P. Nowalk, C. J. Lin, D. E. Fox, F. S. Ko, E. Wettick, G. Cost, L. Hand, J. Hayes, and M. Michaels. 2010. Randomized trial of an alternate human papil- lomavirus vaccine administration schedule in college-aged women. Journal of Women’s Health 19(8):1441-1447. Zipp, F., J. G. Weil, and K. M. Einhaupl. 1999. No increase in demyelinating diseases after hepatitis B vaccination. Nature Medicine 5(9):964-965. Zorzon, M., R. Zivadinov, D. Nasuelli, P. Dolfini, A. Bosco, A. Bratina, M. A. Tommasi, L. Locatelli, and G. Cazzato. 2003. Risk factors of multiple sclerosis: A case-control study. Neurological Sciences 24(4):242-247. ARTICLES REVIEWED BY THE COMMITTEE BUT THE PEER-REVIEW STATUS WAS UNKNOWN Aherne, P., and M. Collins. 1995. Psoriatic arthropathy. Irish Medical Journal 88(2):72. Aksu, K., G. Keser, and E. Doganavsargil. 2006. Reactive arthritis following tetanus and rabies vaccinations. Rheumatology International 27(2):209-210.

OCR for page 749
818 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Albitar, S., B. Bourgeon, R. Genin, M. Fen-Chong, P. N’Guyen, M. O. Serveaux, H. Atchia, and D. Schohn. 1997. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrology Dialysis Transplantation 12(10):2169-2170. Antony, S. J., D. F. Fleming, and T. K. Bradley. 1995. Postvaccinial (influenza) disseminated encephalopathy (Brown-Sequard syndrome). Journal of the National Medical Associa- tion 87(9):705-708. Asakawa, J., S. Kobayashi, K. Kaneda, H. Ogasawara, M. Sugawara, M. Yasuda, and H. Hashimoto. 2005. Reactive arthritis after influenza vaccination: Report of a case. Mod- ern Rheumatology 15(4):283-285. Battaglia, A., and R. Valiani. 1992. Description of case of seizure following anti-hepatitis B immunization [in Italian]. Rassegna di Medicina Sperimentale 39(7-9):119-122. Bedard, P. M., and G. Gascon. 1999. Fatal outcome of systemic vasculitis following influenza vaccination. Canadian Journal of Allergy and Clinical Immunology 4(8):405-406. Beretta, L., M. Caronni, M. Vanoli, and R. Scorza. 2001. Churg-Strauss vasculitis with brain involvement following hepatitis B vaccination. Clinical and Experimental Rheumatology 19(6):757. Biasi, D., A. Carletto, P. Caramaschi, A. Frigo, M. L. Pacor, D. Bezzi, and L. M. Bambara. 1994a. Rheumatic manifestations following hepatitis B vaccination. Two case reports [in Italian]. Recenti Progressi in Medicina 85(9):438-440. Biasi, D., A. Carletto, P. Caramaschi, M. Tonoli, and L. M. Bambara. 1994b. A case of reactive arthritis after influenza vaccination. Clinical Rheumatology 13(4):645. Biasi, D., G. De Sandre, L. M. Bambara, A. Carletto, P. Caramaschi, G. Zanoni, and G. Tridente. 1993. A new case of reactive arthritis after hepatitis B vaccination. Clinical and Experimental Rheumatology 11(2):215. Bilyk, M. A., and G. K. Dubchik. 1978. Anaphylactic reaction following subcutaneous ad- ministration of tetanus anatoxin [in Russian]. Klinicheskaia Meditsina 56(9):137-138. Birck, R., I. Kaelsch, P. Schnuelle, L. F. Flores-Suarez, and R. Nowack. 2009. ANCA- associated vasculitis following influenza vaccination: Causal association or mere coinci- dence? Journal of Clinical Rheumatology 15(6):289-291. Blanco-Marchite, C. I., L. Buznego-Suarez, M. A. Fagundez-Vargas, M. Mendez-Llatas, and P. Pozo-Martos. 2008. Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination [in Spanish]. Archivos de la Sociedad Espanola de Oftalmologia 83(7):433-435. Blanco, A., J. M. Lopez Dominguez, J. L. Casado, and C. Diaz. 1999. Meningoencephalitis: An unusual complication of influenza vaccine [in Spanish]. Medicina Clinica 112(15):597. Bolukbasi, O., and M. Ozmenoglu. 1999. Acute disseminated encephalomyelitis associated with tetanus vaccination. European Neurology 41(4):231-232. Boutros, N., and B. P. Keck. 1993. Delirium following influenza vaccination. American Journal of Psychiatry 150(12):1899. Brinar, V. V., and C. M. Poser. 2008. Disseminated encephalomyelitis in adults. Clinical Neu- rology and Neurosurgery 110(9):913-918. Brooks, R., and A. Reznik. 1980. Guillain-Barré syndrome following trivalent influenza vac- cine in an elderly patient. Mount Sinai Journal of Medicine 47(2):190-191. Brown, M. A., J. V. Bertouch, and J. Edmonds. 1994. Rheumatic complications of influenza vaccination. Australian and New Zealand Journal of Medicine 24(5):572-573. Bui-Quang, D., E. Thomas, M. Riols, P. Levillain, D. Picaud, A. Sechet, M. Baron, and C. Verove. 1998. Cutaneous vasculitis after hepatitis B vaccination with recombinant vac- cine in a renal transplant recipient [in French]. Presse Medicale 27(26):1321-1323.

OCR for page 749
819 APPENDIX E Cabrera-Gomez, J. A., N. Echazabal-Santana, L. Garcia Gonzalez, A. M. Ramos Cedeno, M. O. Rodriguez Roque, O. Lopez Hernandez, J. A. Cabrera Nunez, J. Gonzalez De La Nuez, and L. Tellez. 2002. A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination? [in Spanish]. Revista de Neurologia 34(4):358-363. Casals, J. L., and M. A. Vasquez. 1999. Arthritis after hepatitis B vaccination [in Spanish]. Anales de Medicina Interna 16(11):601-602. Cathebras, P., O. Cartry, M. H. Lafage-Proust, A. Lauwers, S. Acquart, T. Thomas, and H. Rousset. 1996. Arthritis, hypercalcemia, and lytic bone lesions after hepatitis B vaccina- tion. Journal of Rheumatology 23(3):558-560. Cizman, M., M. Pokorn, and D. Osredkar. 2005. Re: Transverse myelitis after measles and rubella vaccination. Journal of Paediatrics & Child Health 41(8):460. de Carvalho, J. F., and Y. Shoenfeld. 2008. Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination. European Journal of Internal Medicine 19(5):383-385. De Keyser, F., J. M. Naeyaert, P. Hindryckx, D. Elewaut, P. Verplancke, I. Peene, M. Praet, and E. Veys. 2000. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clinical and Experimental Rheumatology 18(1):81-85. Deisenhammer, F., P. Pohl, S. Bosch, and C. Schmidauer. 1994. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurologica Scandinavica 89(6):462-463. Delbrel, X., J. Fach, D. Neau, M. Le Bras, and M. Longy Boursier. 1998. Lupus flare-up after hepatitis B vaccination [in French]. Presse Medicale 27(6):260. Drouet, A., L. Guilloton, S. Fresse, and D. Felten. 2002. Meningoencephalitis following an influenza vaccination [in French]. Revue de Medecine Interne 23(8):734. Drucker, Y., R. A. Prayson, A. Bagg, and L. H. Calabrese. 1997. Lymphocytic vasculitis pre- senting as diffuse subcutaneous edema after hepatitis B virus vaccine. Journal of Clinical Rheumatology 3(3):158-161. Eckert, T., C. Bartels, C. Mawrin, H. Feistner, and T. Welte. 2005. A case of influenza vac- cination induced Guillain-Barré syndrome with normal cerebrospinal fluid protein and improvement on treatment with corticosteroids. Scandinavian Journal of Infectious Diseases 37(8):621-623. Erguven, M., S. Guven, U. Akyuz, O. Bilgic, and F. Laloglu. 2009. Optic neuritis following hepatitis B vaccination in a 9-year-old girl. Journal of the Chinese Medical Association 72(11):594-597. Famularo, G., G. C. Nicotra, G. Minisola, and C. De Simone. 2006. Leukocytoclastic vascu- litis after influenza vaccination. Journal of Clinical Rheumatology 12(1):48-50. Finielz, P., L. F. Lam-Kam-Sang, and J. Guiserix. 1998. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrology Dialysis Transplantation 13(9):2420-2421. Finsterer, J., C. Artner, A. Kladosek, R. Kalchmayr, and S. Redtenbacher. 2001. Cavernous sinus syndrome due to vaccination-induced giant cell arteritis. Archives of Internal Medicine 161(7):1008-1009. Froissart, M., J. P. Mizon, and J. L. Leroux. 1978. Acute meningoencephalitis immediately after an influenza vaccination [in French]. Lille Medical 23(8):548-551. Garcia Callejo, F. J., I. Costa Alcacer, C. De Paula Vernetta, and J. Marco Algarra. 2005. Sud- den bilateral deafness after measles, mumps and rubella vaccination [in Spanish]. Anales de Pediatria 62(5):482-483. Garcia Robledo, M. C., S. Hierro Orozco, L. Achell Nava, and V. Jaimes Hernandez. 2010. Leukocytoclastic vasculitis post-vaccination against influenza: A report of a case and bibliographical review [in Spanish]. Dermatologia Revista Mexicana 54(2):80-83.

OCR for page 749
820 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Gardasil—Brachial plexus neuritis [in German]. 2009. Internistische Praxis 49(1):188-189. Garea Garcia-Malvar, M. J., J. A. Moche Loeri, P. Bachiller Luque, and C. Fernandez Gomez. 2004. Acute disseminated encephalomyelitis secondary to influenza vaccination [in Span- ish]. Anales de Medicina Interna 21(9):462-463. Gavaghan, T., and C. K. Webber. 1993. Severe systemic vasculitic syndrome post influenza vaccination. Australian and New Zealand Journal of Medicine 23(2):220. Gerth, H. J. 1992. Polymyalgia rheumatica and influenza vaccination [in German]. Deutsche Medizinische Wochenschrift 117(33):1259-1260. Giampietro, P. G., G. Bruno, M. Grandolfo, and L. Businco. 1993. Adverse reaction to measles immunization. European Journal of Pediatrics 152(1):80. Gold, M., A. Kempe, and M. Osbourn. 1999. A comparison of serious adverse reactions to whole cell and acellular pertussis vaccines in south Australia. Medical Journal of Aus- tralia 171(6):331-332,334. Grasland, A., F. Le Maitre, J. Pouchot, P. Hazera, C. Bazin, and P. Vinceneux. 1998. Adult Still’s disease after hepatitis A and B vaccination? [in French]. Revue de Medecine Interne 19(2):134-136. Gross, K., C. Combe, K. Kruger, and M. Schattenkirchner. 1995. Arthritis after hepatitis B vaccination. Report of three cases. Scandinavian Journal of Rheumatology 24(1):50-52. Guillevin, L., and Y. Levy. 1983. Hypersensitivity reaction following vaccination against in- fluenza [in French]. Presse Medicale 12(26):1668-1669. Hamidon, B. B., and A. A. Raymond. 2003. Acute disseminated encephalomyelitis (ADEM) presenting with seizures secondary to anti-tetanus toxin vaccination. Medical Journal of Malaysia 58(5):780-782. Hartman, S. 1990. Convulsion associated with fever following hepatitis B vaccination. Journal of Paediatrics and Child Health 26(1):65. Healy, C. E. 1972. Mumps vaccine and nerve deafness. American Journal of Diseases of Children 123(6):612. Hong, L., F. Wackers, M. Dewar, M. Kashgarian, and P. W. Askenase. 2000. Atypical fatal hypocomplementemic urticarial vasculitis with involvement of native and homograft aortic valves in an African American man. Journal of Allergy and Clinical Immunology 106(6):1196-1198. Houston, T. P. 1983. Small-vessel vasculitis following simultaneous influenza and pneumococ- cal vaccination. New York State Journal of Medicine 83(11-12):1182-1183. Hu, S. C., C. L. Ke, G. S. Chen, and S. T. Cheng. 2009. Parallel correlation of immuno- fluorescence studies with clinical course in a patient with influenza vaccine-induced lymphocytic vasculitis. Journal of the European Academy of Dermatology and Venereol- ogy 23(4):463-465. Huber, S., L. Kappos, P. Fuhr, S. Wetzel, and A. J. Steck. 1999. Combined acute disseminated encephalomyelitis and acute motor axonal neuropathy after vaccination for hepatitis A and infection with Campylobacter jejuni. Journal of Neurology 246(12):1204-1206. Iniguez, C., J. A. Mauri, P. Larrode, J. Lopez del Val, I. Jerico, and F. Morales. 2000. Acute transverse myelitis secondary to hepatitis B vaccination [in Spanish]. Revista de Neuro- logia 31(5):430-432. Iyngkaran, P., V. Limaye, C. Hill, D. Henderson, K. D. Pile, and M. Rischmueller. 2003. Rheumatoid vasculitis following influenza vaccination. Rheumatology 42(7):907-909. Jacobi, D., F. Maillot, C. Hommet, S. Arsene, J. P. Cottier, F. Lamisse, and L. Guillevin. 2005. P-ANCA cranial pachymeningitis: A case report. Clinical Rheumatology 24(2):174-177. Jayarajan, V., and P. A. Sedler. 1995. Hearing loss following measles vaccination. Journal of Infection 30(2):184-185. Journe, F., F. Deschamps, and M. L. Germain. 1995. Vascularitis and vaccination against hepatitis B [in French]. Archives des Maladies Professionnelles et de Medecine du Travail 56(1):48.

OCR for page 749
821 APPENDIX E Jover-Saenz, A., E. M. Fernandez, S. Garrido-Calvo, and J. M. Porcel-Perez. 2008. Postvaccine temporal arteritis [in Spanish]. Medicina Clinica 130(16):638-639. Kakar, A., and P. K. Sethi. 1997. Guillain Barré syndrome associated with hepatitis B vaccina- tion. Indian Journal of Pediatrics 64(5):710-712. Kao, C. D., J. T. Chen, K. P. Lin, D. E. Shan, Z. A. Wu, and K. K. Liao. 2004. Guillain-Barré syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination. Clinical Neurology and Neurosurgery 106(2):136-138. Kasper, H. U., V. Dries, U. Drebber, D. Stippel, K. Reinhold, and H. P. Dienes. 2004. Florid ischemic cholangitis due to leucocytoclastic vasculitis. Journal of Gastroenterology 39(2): 188-191. Kato, T., A. Kiire, H. Yamagata, H. Yamanaka, and N. Kamatani. 2006. Hypersensitivity reac- tion against influenza vaccine in a patient with rheumatoid arthritis after the initiation of etanercept injections. Modern Rheumatology 16(5):327-329. Kavadas, F., A. Bitnun, D. MacGregor, H. Heurter, and E. Lee Ford Jones. 2008. Acute neuro- logical events associated with influenza vaccination: Are the WHO criteria for assessing causality adequate? Scandinavian Journal of Infectious Diseases 40(6-7):565-570. Kaygusuz, S., A. K. Erdemoglu, and I. Koksal. 2002. Afebrile convulsion in an adult af- ter recombinant hepatitis B vaccination. Scandinavian Journal of Infectious Diseases 34(4):314-315. Kelkar, P. 2006. Chronic inflammatory demyelinating polyneuropathy (CIDP) with rapid progression after influenza vaccination: A report of three cases. Journal of Clinical Neu- romuscular Disease 8(1):20-25. Kelsall, J. T., A. Chalmers, C. H. Sherlock, V. A. Tron, and A. C. Kelsall. 1997. Microscopic polyangiitis after influenza vaccination. Journal of Rheumatology 24(6):1198-1202. Kennedy, M. J., J. M. Carpenter, R. A. Lozano, and R. G. Castile. 2002. Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler. Annals of Allergy, Asthma, and Immunology 88(5):523-526. Kerleau, J. M., H. Levesque, G. Lair, F. Lecomte, O. Carrara, and H. Courtois. 1997. Is hepa- titis B vaccination a new cause of necrotizing vasculitis? [in French]. Revue de Medecine Interne 18(6):491-492. Khamaisi, M., Y. Shoenfeld, and H. Orbach. 2004. Guillain-Barré syndrome following hepa- titis B vaccination. Clinical and Experimental Rheumatology 22(6):767-770. Konkel, G., C. Runge, U. Szillat, S. Wiersbitzky, R. Bruns, and U. Schmidt. 1993. Cerebral convulsions: Encephalitis following MMR, OPV, HiB or DPT vaccination? [in German]. Kinderarztliche Praxis 61(6):232-234. Langsjoen, P. H., and J. C. Stinson. 1965. Acute fatal allergic myocarditis. Report of a case. Diseases of the Chest 48(4):440-441. Le Goff, P., P. Fauquert, P. Youinou, and S. Hoang. 1988. Periarteritis nodosa following im- munization against hepatitis B [in French]. Presse Medicale 17(34):1763. Le Goff, P., P. Fauquert, P. Youinou, and S. Hoang. 1991. Periarteritis nodosa (PAN) following vaccine against hepatitis B [in French]. Rhumatologie 43(3):79. Le Hello, C., P. Cohen, M. G. Bousser, P. Letellier, and L. Guillevin. 1999. Suspected hepatitis B vaccination related vasculitis. Journal of Rheumatology 26(1):191-194. Lee, S. Y., D. M. Komp, and W. Andiman. 1986. Thrombocytopenic purpura follow- ing varicella zoster vaccination. American Journal of Pediatric Hematology/Oncology 8(1):78-80. Liozon, E., R. Ittig, N. Vogt, J. P. Michel, and G. Gold. 2000. Polymyalgia rheumatica follow- ing influenza vaccination. Journal of the American Geriatrics Society 48(11):1533-1534. Llobat Estelles, T., M. J. Benlloch Muncharaz, L. Santos Serrano, J. M. Paricio Talayero, J. Martin Ruano, and M. Grieco Burucua. 1995. Hepatitis B vaccine associated with erythema nodosum. A case report [in Spanish]. Anales Espanoles de Pediatria 42(2):149.

OCR for page 749
822 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Lohiya, G.-S., L. Tan-Figueroa, S. Reddy, and S. Marshall. 2004. Chickenpox and pneumonia following varicella vaccine. Infection Control and Hospital Epidemiology 25(7):530. Lohse, A., F. Michel, B. Auge, E. Toussirot, and D. Wendling. 1999. Vascular purpura and cryoglobulinemia after influenza vaccination: Case-report and literature review. Revue du Rhumatisme (English Edition) 66(6):359-360. Mader, R., A. Narendran, J. Lewtas, V. Bykerk, R. C. J. Goodman, J. R. Dickson, and E. C. Keystone. 1993. Systemic vasculitis following influenza vaccination—report of 3 cases and literature review. Journal of Rheumatology 20(8):1429-1431. Mahassin, F., J. P. Algayres, J. Valmary, H. Bili, G. Coutant, D. Bequet, and J. P. Daly. 1993. Acute myelitis following hepatitis B vaccination [in French]. Presse Medicale 22(40):1997-1998. Mamoux, V., and C. Dumont. 1994. Systemic lupus erythematosus and vaccination against hepatitis B virus [in French]. Archives de Pediatrie 1(3):307-308. Manna, R., A. De Santis, A. Oliviero, A. Carnevale, S. Caputo, M. Pahor, A. Laudisio, and G. Gasbarrini. 1996. Leukoencephalitis after recombinant hepatitis B vaccine. Journal of Hepatology 24(6):764-765. Masse, I., and M. C. Descoffres. 1998. Hypersensitivity vasculitis after hepatitis B vaccination [in French]. Presse Medicale 27(20):965-966. Mendoza Plasencia, Z., M. Gonzalez Lopez, M. L. Fernandez Sanfiel, and J. R. Muniz Montes. 2010. Acute disseminated encephalomyelitis with tumefactive lesions after vaccination against human papillomavirus [in Spanish]. Neurologia 25(1):58-59. Miron, D., D. Fink, and P. J. Hashkes. 2003. Kawasaki disease in an infant following immuni- sation with hepatitis B vaccine. Clinical Rheumatology 22(6):461-463. Molina, M., G. Ortega, J. Galvez, and L. Munoz. 1990. Leukocytoclastic vasculitis secondary to flu vaccination [in Spanish]. Medicina Clinica 95(2):78. Moon, J. S., and N. Souayah. 2006. Guillain-Barré syndrome triggered by influenza vaccina- tion in a recipient of liver transplant on FK506. Liver Transplantation 12(10):1537-1539. Nakajima, H., S. Ohtsuka, T. Nishina, M. Sugino, F. Kimura, T. Hanafusa, T. Ikemoto, and A. Shimizu. 2003. Multiple sclerosis after allergen-specific immunotherapy and influenza vaccination. European Neurology 50(4):248-249. Nakamura, N., K. Nokura, T. Zettsu, H. Koga, M. Tachi, M. Terada, H. Katoh, Y. Itoh, H. Osawa, T. Ozeki, and H. Yamamoto. 2003. Neurologic complications associated with influenza vaccination: Two adult cases. Internal Medicine 42(2):191-194. Naruse, H., H. Miwata, T. Ozaki, Y. Asano, J. Namazue, and K. Yamanishi. 1993. Varicella infection complicated with meningitis after immunization. Acta Paediatrica Japonica 35(4):345-347. Newton, N., Jr., and A. Janati. 1987. Guillain-Barré syndrome after vaccination with purified tetanus toxoid. Southern Medical Journal 80(8):1053-1054. Otsuka, T., Y. Gomi, N. Inoue, and M. Uchiyama. 2009. Transmission of varicella vaccine virus, Japan. Emerging Infectious Diseases 15(10):1702-1703. Palao Sanchez, A., C. Leiva-Santana, C. Munoz-Ruiz, and J. Sanchez-Paya. 1997. Neuro- logical involvement following triple virus vaccine [in Spanish]. Revista de Neurologia 25(137):75-77. Pelosio, A., A. Galassi, R. Massini, C. Longhi, P. Marchetti, and U. Recine. 1990. Influenza vaccination and Guillain-Barré syndrome [in Italian]. Medicina—Rivista della Enciclo- pedia Medica Italiana 10(2):169. Perez, C., E. Loza, and T. Tinture. 2000. Giant cell arteritis after influenza vaccination. Archives of Internal Medicine 160(17):2677. Pou, M. A., C. Diaz-Torne, S. Vidal, C. Corchero, J. Narvaez, J. M. Nolla, and C. Diaz-Lopez. 2008. Development of autoimmune diseases after vaccination. Journal of Clinical Rheu- matology 14(4):243-244.

OCR for page 749
823 APPENDIX E Ravaglia, S., M. Ceroni, A. Moglia, A. Todeschini, and E. Marchioni. 2004. Post-infectious and post-vaccinal acute disseminated encephalomyelitis occurring in the same patients. Journal of Neurology 251(9):1147-1150. Renard, J. L., J. S. Guillamo, J. M. Ramirez, H. Taillia, D. Felten, and Y. Buisson. 1999. Acute cervical transverse myelitis after anti-hepatitis B vaccination: Time course of anti-HBs antibodies [in French]. Presse Medicale 28(24):1290-1292. Riel-Romero, R. M. S. 2006. Acute transverse myelitis in a 7-month-old boy after diphtheria- tetanus-pertussis immunization. Spinal Cord 44(11):688-691. Riikonen, R. S. 1995. Retinal vasculitis caused by rubella. Neuropediatrics 26(3):174-176. Rogalewski, A., J. Kraus, M. Hasselblatt, C. Kraemer, and W. R. Schabitz. 2007. Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis. Neuropsy- chiatric Disease and Treatment 3(6):987-991. Saadoun, D., P. Cacoub, D. Mahoux, A. Sbai, and J. C. Piette. 2001. Vasculitis compli- cating vaccination: A report of three cases [in French]. Revue de Medecine Interne 22(2):172-176. Sahin, N., A. Salli, A. U. Enginar, and H. Ugurlu. 2009. Reactive arthritis following tetanus vaccination: A case report. Modern Rheumatology 19(2):209-211. Salemi, S., A. Picchianti-Diamanti, V. Germano, I. Donatelli, A. Di Martino, M. Facchini, R. Nisini, R. Biselli, C. Ferlito, E. Podesta, A. Cappella, F. Milanetti, F. Rossi, R. Amodeo, F. Tabacco, R. Di Rosa, B. Lagana, and R. D’Amelio. 2010. Influenza vaccine administra- tion in rheumatoid arthritis patients under treatment with TNF alpha blockers: Safety and immunogenicity. Clinical Immunology 134(2):113-120. Saliba, W. R., and M. Elias. 2005. Acute hepatitis following MMR vaccination. European Journal of Internal Medicine 16(5):379. Santoro, D., M. Stella, G. Montalto, and S. Castellino. 2007. Lupus nephritis after hepatitis B vaccination: An uncommon complication. Clinical Nephrology 67(1):61-63. Schaffer, V., S. Wimmer, I. Rotaru, R. Topakian, H. P. Haring, and F. T. Aichner. 2008. HPV vaccine: A cornerstone of female health a possible cause of ADEM? Journal of Neurol- ogy 255(11):1818-1820. Sebag, O., G. Bolla, B. Bebin, and F. Sebag. 1998. Exacerbation of chronic juvenile arthritis induced by hepatitis B vaccination [in French]. Archives de Pediatrie 5(9):1046. Senecal, J. L., C. Bertrand, and F. Coutlee. 1999. Severe exacerbation of systemic lupus erythematosus after hepatitis B vaccination and importance of pneumococcal vaccination in patients with autosplenectomy: Comment on the article by Battafarano et al. Arthritis & Rheumatism 42(6):1307-1308. Seti, N. K., R. Reddi, I. Anand, and P. K. Sethi. 2002. Gulliane Barré syndrome following vaccination with hepatitis B vaccine. Journal of the Association of Physicians of India 50:989. Shuper, A. 2011. Suspected measles-mumps-rubella vaccine-related encephalitis: Two cases. Scandinavian Journal of Infectious Diseases 43(1):75-78. Sinaniotis, C. A., E. Daskalopoulou, P. Lapatsanis, and S. Doxiadis. 1975. Letter: Diabetes mellitus after mumps vaccination. Archives of Disease in Childhood 50(9):749-750. Sinsawaiwong, S., and P. Thampanitchawong. 2000. Guillain-Barré syndrome following re- combinant hepatitis B vaccine and literature review. Journal of the Medical Association of Thailand 83(9):1124-1126. Soubrier, M., J. J. Dubost, C. Bielsa, J. M. Ristori, and J. L. Bussiere. 1997. Erosive polyar- thritis triggered by vaccination against hepatitis B [in French]. Presse Medicale 26(2):75. Spaetgens, B., P. van Paassen, and J. W. C. Tervaert. 2009. Influenza vaccination in ANCA- associated vasculitis. Nephrology Dialysis Transplantation 24(10):3258; author reply 3259.

OCR for page 749
824 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Steinberg, P., M. J. Belgrade, and D. C. Anderson. 1995. Reflex sympathetic dystrophy: An adverse reaction to immunotherapy. Journal of Allergy and Clinical Immunology 95(3):775-776. Stevenson, V. L., J. F. Acheson, J. Ball, and G. T. Plant. 1996. Optic neuritis following measles/rubella vaccination in two 13-year-old children. British Journal of Ophthalmology 80(12):1110-1111. Stewart, O., B. Chang, and J. Bradbury. 1999. Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis. British Journal of Ophthalmology 83(10):1200-1201. Sutton, I., R. Lahoria, I. Tan, P. Clouston, and M. Barnett. 2009. CNS demyelination and quadrivalent HPV vaccination. Multiple Sclerosis 15(1):116-119. Tavadia, S., A. Drummond, C. D. Evans, and N. J. Wainwright. 2003. Leucocytoclastic vas- culitis and influenza vaccination. Clinical and Experimental Dermatology 28(2):154-156. Terney, D., S. Beniczky, P. Barsi, I. Kondakor, J. Perenyi, A. Faludi, M. Szapper, and L. Vecsei. 2006. Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient. Chinese Medical Journal 119(1):77-79. Treves, R., L. Lacoste, D. Bontoux, E. Pitrou, P. Bertin, and C. Bonnet. 1997. Erosive nodular rheumatoid arthritis triggered by hepatitis B vaccination [in French]. Presse Medicale 26(14):670. Tuohy, P. G. 1989. Guillain-Barré syndrome following immunisation with synthetic hepatitis B vaccine. New Zealand Medical Journal 102(863):114-115. Uji, M., H. Matsushita, and S. Iwata. 2005. Microscopic polyangiitis after influenza vaccina- tion. Internal Medicine 44(8):892-896. Uriondo San Juan, B., D. Naval Valle, and F. Moreno Izco. 2004. Guillain-Barré syndrome after immunisation with hepatitis A and typhoid vaccines [in Spanish]. Atencion Primaria 34(7):379. Vaandrager, G. J., J. L. Molenaar, G. J. Bruining, A. D. Plantinga, and E. J. Ruitenberg. 1986. Islet cell antibodies, mumps infection and mumps vaccination. Diabetologia 29(6): 406-407. Vainer-Mossel, E. D., Y. A. Mekori, and A. Mor. 2009. Ischemic stroke in a patient with lupus following influenza vaccination: A questionable association. Israel Medical Association Journal 11(3):186-187. Wada, Y., C. Yanagihara, Y. Nishimura, and N. Oka. 2008. Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination. Clinical Neurology and Neurosurgery 110(7):750-752. Walker, S. L., K. J. Swindells, and R. J. G. Chalmers. 2004. Leucocytoclastic vasculitis and influenza immunization. Clinical and Experimental Dermatology 29(1):95-96. Watson, J. G. 1990. Letter to the editor. International Journal of Pediatric Otorhinolaryngol- ogy 19(2):189-190. Wattiaux, M. J., L. Moulonguet-Doleris, J. Cabane, J. Lebas, and J. C. Imbert. 1988. Rheumatoid purpura following influenza vaccination [in French]. Presse Medicale 17(13):649-650. Wiersbitzky, S., R. Bruns, and B. Beyer. 1992a. Incubation vaccination (“post-exposure vacci- nation”) with MMR vaccine during a mumps epidemic? The pediatric vaccine counseling unit [in German]. Kinderarztliche Praxis 60(7):207-208. Wiersbitzky, S., R. Bruns, and R. Mentel. 1993a. Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination? [in German]. Kinderarztliche Praxis 61(6):227-228. Wiersbitzky, S., R. Bruns, A. Peters, and R. Mentel. 1992b. Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The pediatric vaccination counseling unit [in German]. Kinderarztliche Praxis 60(7):203-205.

OCR for page 749
825 APPENDIX E Wiersbitzky, S., R. Bruns, and U. Schmidt. 1993b. Cerebral seizures and/or encephalitis after MMR, oral polio, HiB or DPT vaccination? [in German]. Kinderarztliche Praxis 61(6):232-234. Wiersbitzky, S., C. Burtzlaff, H. Wiersbitzky, and R. Bruns. 1995. Postvaccinal convulsions and epilepsy [in German]. Sozialpadiatrie und Kinderarztliche Praxis 17(9):517-519. Wiersbitzky, S., C. Schroder, and C. Burtzlaff. 1991. Vaccination encephalopathy after measles vaccination simulating recurrent cardiovascular dysregulation? The pediatric vaccination counseling unit [in German]. Kinderarztliche Praxis 59(6):187-188. Yahr, M. D., and J. Lobo-Antunes. 1972. Relapsing encephalomyelitis following use of influ- enza vaccine. Archives of Neurology 27(2):182-183. Yanai-Berar, N., O. Ben-Itzhak, J. Green, and F. Nakhoul. 2002. Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clinical Nephrology 58(3):220-223. Zaloga, G. P., and B. Chernow. 1982. Life-threatening anaphylactic reaction to tetanus toxoid. Annals of Allergy 49(2):107-108. Zheng, W., and S. C. Dreskin. 2007. Thimerosal in influenza vaccine: An immediate hypersen - sitivity reaction. Annals of Allergy, Asthma and Immunology 99(6):574-575. ARTICLES REVIEWED BY THE COMMITTEE BUT DETERMINED TO NOT BE PEER-REVIEWED Barbor, P. R., and D. B. Grant. 1969. Encephalitis after measles vaccination. Lancet 294(7610): 55-56. Bodor, M., and E. Montalvo. 2007. Vaccination-related shoulder dysfunction. Vaccine 25(4): 585-587. Boulianne, N., G. De Serres, B. Duval, R. Shadmani, and L. Rochette. 2001. Clinical manifes- tations and incidence of oculo-respiratory syndrome following influenza vaccination— Quebec, 2000. Canada Communicable Disease Report 27(10):85-90. Catania, P., and I. Pela. 2010. Vasculitis in a boy with ESRD following influenza vaccination. Vaccine 28 (4):877-878. CDC (Centers for Disease Control and Prevention). 2005. Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June-July 2005. Morbidity & Mortality Weekly Report 54(40):1023-1025. CDC. 2006a. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, June 2005-September 2006. Morbidity & Mortality Weekly Report 55(41):1120-1124 [erratum appears in MMWR 1155(1143):1177]. CDC. 2006b. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine—United States, October 2005-February 2006. Morbidity & Mortality Weekly Report 55(13):364-366. CDC. 2008. Syncope after vaccination—United States, January 2005-July 2007. Morbidity & Mortality Weekly Report 57(17):457-460. Cimmino, M. A., B. Seriolo, S. Accardo, and A. Chalmers. 1995. Influenza vaccination in rheumatoid arthritis. Journal of Rheumatology 22(9):1802-1803. Di Giusto, C. A., and J. D. Bernhard. 1986. Erythema nodosum provoked by hepatitis B vac- cine. Lancet 2(8514):1042. Ehrengut, W. 1989. Mumps vaccine and meningitis. Lancet 334(8665):751. Fineschi, S. 2001. Can recombinant anti-hepatitis B vaccine be a cause of systemic lupus erythematosus? Lupus 10(11):830. Graus, F., T. Ribalta, and G. Ribera. 1987. Acute necrotic myelopathy associated with influ- enza vaccination. Lancet 1(8545):1311-1312.

OCR for page 749
826 ADVERSE EFFECTS OF VACCINES: EVIDENCE AND CAUSALITY Grenier, J. L., E. Toth, G. De Serres, S. Menard, R. Roussel, M. Tremblay, M. Landry, Y. Robert, and D. M. Skowronski. 2004. Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination. Canada Communi- cable Disease Report 30(2):9-16. Hull, J. H. K., S. H. Mead, O. J. Foster, and H. Modarres-Sadeghi. 2004. Severe vasculitic neuropathy following influenza vaccination. Journal of Neurology, Neurosurgery and Psychiatry 75(10):1507-1508. Kaplanski, G., F. Retornaz, J. Durand, and J. Soubeyrand. 1995. Central nervous system demy- elination after vaccination against hepatitis B and HLA haplotype. Journal of Neurology, Neurosurgery and Psychiatry 58(6):758-759. Knight, R. S. G., J. S. Duncan, C. J. F. Davis, and C. P. Warlow. 1984. Influenza vaccination and Guillain-Barré syndrome. Lancet 1(8373):394. Kuruma, K. A. M., E. F. Borba, M. H. Lopes, J. F. de Carvalho, and E. Bonfa. 2007. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 16(5):350-354. Lear, J. T., and J. S. English. 1995. Anaphylaxis after hepatitis B vaccination. Lancet 345(8959): 1249. Miller, D., J. Wadsworth, J. Diamond, and E. Ross. 1997. Measles vaccination and neurologi- cal events. Lancet 349(9053):730-731. Morris, K., and G. Rylance. 1994. Guillain-Barré syndrome after measles, mumps, and rubella vaccine. Lancet 343(8888):60. Nadler, J. P. 1993. Multiple sclerosis and hepatitis B vaccination. Clinical Infectious Diseases 17(5):928-929. National Advisory Committee on Immunization. 2001. Statement on influenza vaccination for the 2001-2002 season. Canada Communicable Disease Report 27(4):1-24. Perumalswami, P., L. Peng, and J. A. Odin. 2009. Vaccination as a triggering event for auto- immune hepatitis. Seminars in Liver Disease 29(3):331-334. Plesner, A. M. 1995. Gait disturbances after measles, mumps, and rubella vaccine. Lancet 345(8945):316. Pritchard, J., R. Mukherjee, and R. A. C. Hughes. 2002. Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following im- munisation. Journal of Neurology, Neurosurgery, and Psychiatry 73(3):348-349. Read, S. J., G. J. Schapel, and M. P. Pender. 1992. Acute transverse myelitis after tetanus toxoid vaccination. Lancet 339(8801):1111-1112. Reijneveld, J. C., M. J. B. Taphoorn, T. U. Hoogenraad, and J. Van Gijn. 1997. Severe but transient parkinsonism after tetanus vaccination. Journal of Neurology Neurosurgery and Psychiatry 63(2):258. Schneck, S. A., V. Fulginiti, and J. Leestma. 1967. Measles virus and panencephalitis. Lancet 1(7504):1381-1382. Shapiro, E., and J. K. Burd. 2000. Comment on the article “Can immunization precipitate connective tissue disease? Report of 5 cases of systemic lupus erythematosus and review of the literature.” Seminars in Arthritis and Rheumatism 30(3):215-216. Stratta, P., R. Cremona, E. Lazzarich, M. Quaglia, R. Fenoglio, and C. Canavese. 2008. Life-threatening systemic flare-up of systemic lupus erythematosus following influenza vaccination. Lupus 17(1):67-68. Tingle, A. J., C. H. Pot, and J. K. Chantler. 1984. Prolonged arthritis, viraemia, hypo- gammaglobulinaemia, and failed seroconversion following rubella immunisation. Lancet 323(8392):1475-1476. Topaloglu, H., M. Berker, T. Kansu, U. Saatci, and Y. Renda. 1992. Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet 339(8786):178-179. Winer, J. B., R. A. C. Hughes, G. W. Bradley, and J. W. Scadding. 1984. Guillain-Barré syn- drome and influenza vaccine. Lancet 1(8387):1182. Woo, E. J., R. Ball, and M. Miles Braun. 2005. Fatal syncope-related fall after immunization. Archives of Pediatrics and Adolescent Medicine 159(11):1083.